Are you Dr. Rezazadeh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
333 Pine Ridge Blvd
Wausau, WI 54401Phone+1 715-847-2866
Summary
- Dr. Hamied Rezazadeh, MD is an oncologist in Wausau, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Michigan, and Maryland. He is affiliated with Aspirus Wausau Hospital, Inc. and Aspirus Langlade Hospital.
Education & Training
- Greater Baltimore Medical CenterResidency, Internal Medicine, 1987 - 1989
- St. George's University School of MedicineClass of 1987
Certifications & Licensure
- WI State Medical License 1990 - 2025
- MI State Medical License 2011 - 2024
- MD State Medical License 1988 - 1995
Clinical Trials
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL Start of enrollment: 2005 Apr 14
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Join now to see all
Publications & Presentations
PubMed
- 41 citationsPhase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer.Glenn Liu, Kurt R. Oettel, Howard H. Bailey, Lynn Van Ummersen, Kendra D. Tutsch
Investigational New Drugs. 2003-08-01
Professional Memberships
- Member
- Member